Study of THDBH120 for weight loss in overweight or obese adults
Part of Hormones & metabolism clinical trials.
This trial tests an injection called THDBH120 to help people who are overweight or obese lose weight. You may qualify if you have a BMI of 28 or higher, or a BMI of 24 to 28 with a weight-related health issue like prediabetes or high blood pressure, and you have been exercising and eating healthy for the past 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a BMI of 28 or more, or a BMI between 24 and 28 with at least one weight-related health problem (like prediabetes, high blood pressure, fatty liver, or joint pain).
- You have been trying to lose weight with diet and exercise for at least 3 months and your weight has stayed mostly the same (changed less than 5%).
- You do not have diabetes.
- Your high blood pressure is well-controlled (systolic under 160 and diastolic under 100).
- Your heart rhythm is normal on an ECG (no slow or fast resting heart rate, no long QT or heart block).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This study tests an investigational injection called UBT251 to help people who are overweight or obese lose weight. It may also improve related health issues like high blood pressure or fatty liver. The trial lasts for a period and includes regular check-ins with the study team.
This study tests a new injectable medication to help adults with obesity or overweight who don't have diabetes lose weight. It involves a reduced-calorie diet and exercise plan, and may offer an effective treatment option for weight management.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
Hear when a new Overweight or Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.